Morgan Stanley analyst Jeffrey Hung has reallocated ratings and adjusted price targets across the bank’s biotech research coverage.The analyst downgraded ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE